Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study.

Labisa P, Andreozzi V, Mota M, Monteiro S, Alves R, Almeida J, Vandewalle B, Felix J, Buesch K, Canhão H, Beitia Ortiz de Zarate I.

Open source

DOI
10.1007/s41669-021-00303-5
Published
2021-10-03
Container
Pharmacoecon Open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s41669-021-00303-5,
  title = {Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study.},
  author = {Labisa P and  Andreozzi V and  Mota M and  Monteiro S and  Alves R and  Almeida J and  Vandewalle B and  Felix J and  Buesch K and  Canhão H and  Beitia Ortiz de Zarate I.},
  year = {2022},
  journal = {Pharmacoecon Open},
  doi = {10.1007/s41669-021-00303-5},
  url = {https://doi.org/10.1007/s41669-021-00303-5}
}

RIS

TY  - JOUR
TI  - Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study.
AU  - Labisa P
AU  -  Andreozzi V
AU  -  Mota M
AU  -  Monteiro S
AU  -  Alves R
AU  -  Almeida J
AU  -  Vandewalle B
AU  -  Felix J
AU  -  Buesch K
AU  -  Canhão H
AU  -  Beitia Ortiz de Zarate I.
PY  - 2022
JO  - Pharmacoecon Open
DO  - 10.1007/s41669-021-00303-5
UR  - https://doi.org/10.1007/s41669-021-00303-5
ER  - 

APA

P, L., V, A., M, M., S, M., R, A., J, A., B, V., J, F., K, B., H, C., & I., B. O. D. Z. (2022). Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study.. Pharmacoecon Open. https://doi.org/10.1007/s41669-021-00303-5

Source records